"Macular Degeneration" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Degenerative changes in the RETINA usually of older adults which results in a loss of vision in the center of the visual field (the MACULA LUTEA) because of damage to the retina. It occurs in dry and wet forms.
| Descriptor ID |
D008268
|
| MeSH Number(s) |
C11.768.585.439
|
| Concept/Terms |
Macular Degeneration- Macular Degeneration
- Degeneration, Macular
- Degenerations, Macular
- Macular Degenerations
- Age-Related Maculopathies
- Age Related Maculopathies
- Macular Degeneration, Age-Related
- Macular Dystrophy
- Dystrophies, Macular
- Dystrophy, Macular
- Macular Dystrophies
- Maculopathies, Age-Related
- Maculopathies, Age Related
- Maculopathy, Age-Related
- Maculopathy, Age Related
- Age-Related Macular Degeneration
- Age Related Macular Degeneration
- Age-Related Macular Degenerations
- Degeneration, Age-Related Macular
- Degenerations, Age-Related Macular
- Macular Degenerations, Age-Related
- Age-Related Maculopathy
- Age Related Maculopathy
|
Below are MeSH descriptors whose meaning is more general than "Macular Degeneration".
Below are MeSH descriptors whose meaning is more specific than "Macular Degeneration".
This graph shows the total number of publications written about "Macular Degeneration" by people in this website by year, and whether "Macular Degeneration" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1999 | 1 | 1 | 2 |
| 2000 | 2 | 0 | 2 |
| 2001 | 2 | 0 | 2 |
| 2002 | 10 | 0 | 10 |
| 2003 | 1 | 1 | 2 |
| 2004 | 5 | 2 | 7 |
| 2005 | 8 | 1 | 9 |
| 2006 | 10 | 3 | 13 |
| 2007 | 18 | 0 | 18 |
| 2008 | 10 | 0 | 10 |
| 2009 | 8 | 1 | 9 |
| 2010 | 9 | 1 | 10 |
| 2011 | 3 | 5 | 8 |
| 2012 | 2 | 1 | 3 |
| 2013 | 4 | 0 | 4 |
| 2014 | 7 | 2 | 9 |
| 2015 | 6 | 0 | 6 |
| 2016 | 3 | 0 | 3 |
| 2017 | 5 | 1 | 6 |
| 2018 | 4 | 1 | 5 |
| 2019 | 0 | 1 | 1 |
| 2020 | 4 | 0 | 4 |
| 2021 | 12 | 0 | 12 |
| 2022 | 4 | 0 | 4 |
| 2023 | 13 | 1 | 14 |
| 2024 | 2 | 4 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Macular Degeneration" by people in Profiles.
-
Alshaikhsalama AM, Alsoudi AF, Wai KM, Koo E, Mruthyunjaya P, Rahimy E. Association between Obstructive Sleep Apnea and Age-related Macular Degeneration Development and Progression. Ophthalmol Retina. 2025 Jun; 9(6):537-545.
-
Borrelli E, Cappellani F, Pulido JS, Pauleikhoff D, Bhutto IA, McLeod DS, Reibaldi M, Edwards MM. The Umbra and the Penumbra: Longitudinal Effects of Geographic Atrophy in AMD on the Outer Choroid by Imaging Analysis and Histopathological Correlation. Invest Ophthalmol Vis Sci. 2024 12 02; 65(14):2.
-
Alsoudi AF, Wai KM, Koo E, Mruthyunjaya P, Rahimy E. Curcuma-Based Nutritional Supplements and Risk of Age-Related Macular Degeneration. JAMA Ophthalmol. 2024 12 01; 142(12):1114-1121.
-
Lin TY, Hsieh YT, Garg SJ, Chen LJ, Chen KJ, Wu WC, Lai CC, Hwang YS, Kang EY. Systemic effects of anti-VEGF intravitreal injection in patients with age-related macular degeneration: A multi-institutional real-world study. Indian J Ophthalmol. 2024 11 01; 72(Suppl 5):S809-S815.
-
Wheeler S, Mahmoudzadeh R, Randolph J. Treatment for dry age-related macular degeneration: where we stand in 2024. Curr Opin Ophthalmol. 2024 Sep 01; 35(5):359-364.
-
Colucciello M. Letter to the Editor: Steroid/AntiVascular Endothelial Growth Factor Combination Therapy for Neovascular Age-Related Macular Degeneration. J Ocul Pharmacol Ther. 2024 04; 40(3):197-198.
-
Samanta A, Alsoudi AF, Rahimy E, Chhablani J, Weng CY. Imaging Modalities for Dry Macular Degeneration. Int Ophthalmol Clin. 2024 Jan 01; 64(1):35-55.
-
Garg A, Nanji K, Tai F, Phillips M, Zeraatkar D, Garg SJ, Sadda SR, Kaiser PK, Guymer RH, Sivaprasad S, Wykoff CC, Chaudhary V. The effect of complement C3 or C5 inhibition on geographic atrophy secondary to age-related macular degeneration: A living systematic review and meta-analysis. Surv Ophthalmol. 2024 May-Jun; 69(3):349-361.
-
Sobh M, Lagali PS, Ghiasi M, Montroy J, Dollin M, Hurley B, Leonard BC, Dimopoulos I, Lafreniere M, Fergusson DA, Lalu MM, Tsilfidis C. Safety and Efficacy of Adeno-Associated Viral Gene Therapy in Patients With Retinal Degeneration: A Systematic Review and Meta-Analysis. Transl Vis Sci Technol. 2023 11 01; 12(11):24.
-
Pandit SA, Momenaei B, Wakabayashi T, Mansour HA, Vemula S, Durrani AF, Pashaee B, Kazan AS, Ho AC, Klufas M, Regillo C, Yonekawa Y, Hsu J, Kuriyan A, Chiang A. Clinical Outcomes of Faricimab in Patients with Previously Treated Neovascular Age-Related Macular Degeneration. Ophthalmol Retina. 2024 04; 8(4):360-366.